James Finlayson
@Elequin Capital, Lp
Latest period2024 - Q3ReportedManaged Assets$896.546MTotal holdings375
Assets growth rate137.21%Assets growth rate (2-Q avg)35.41%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Elequin Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 375 positions.
Assets under management
The assets under management (AUM) of Elequin Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 896.546M in assets, with a quarterly growth rate of 137.21% and a 2-quarter average growth rate of 35.41%. The portfolio is managed by James Finlayson, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CRICarters Inc
| 0% | $12,828 207 shares@ $61.98 avg price | Exited |
GCIGannett Co Inc
| 0% | $12,553 2,723 shares@ $4.61 avg price | Exited |
PANWPalo Alto Networks Inc
| 0% | $9,831 29 shares@ $339.0 avg price | Exited |
ISRGIntuitive Surgical Inc
| 0% | $9,342 21 shares@ $444.86 avg price | Exited |
CSCOCisco Sys Inc
| 0% | $9,312 196 shares@ $47.52 avg price | Exited |
RJFRaymond James Finl Inc
| 0% | $9,271 75 shares@ $123.62 avg price | Exited |
XLESelect Sector Spdr Tr
| 0% | $9,206 101 shares@ $91.15 avg price | Exited |
JPMJpmorgan Chase & Co.
| 0% | $9,102 45 shares@ $202.27 avg price | Exited |
RVMDRevolution Medicines Inc
| 0% | $9,082 234 shares@ $38.82 avg price | Exited |
SIRISirius Xm Holdings Inc
| 0% | $9,079 3,208 shares@ $2.84 avg price | Exited |